Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial (Q34985342)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial |
scientific article |
Statements
1 reference
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial (English)
1 reference
Henning Beck-Nielsen
1 reference
Markolf Hanefeld
1 reference
Michel Komajda
1 reference
John J V McMurray
1 reference
Ramon Gomis
1 reference
Paula S Curtis
1 reference
Philip D Home
1 reference
Stuart J Pocock
1 reference
Nigel P Jones
1 reference
RECORD Study Team
1 reference
Identifiers
1 reference